Literature DB >> 16206096

Candidemia is costly--plain and simple.

Scott K Fridkin.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16206096     DOI： 10.1086/496935

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  11 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Adjunctive immunotherapy in combination with lipid-associated amphotericin B for the treatment of invasive candidiasis.

Authors:  Stanley Chapman
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.725

Review 3.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

4.  Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011.

Authors:  Angela Ahlquist Cleveland; Monica M Farley; Lee H Harrison; Betsy Stein; Rosemary Hollick; Shawn R Lockhart; Shelley S Magill; Gordana Derado; Benjamin J Park; Tom M Chiller
Journal:  Clin Infect Dis       Date:  2012-08-14       Impact factor: 9.079

5.  Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated In Vitro Pharmacokinetic/Pharmacodynamic Model.

Authors:  Maria-Ioanna Beredaki; Panagiota-Christina Georgiou; Maria Siopi; Lamprini Kanioura; David Andes; Maiken Cavling Arendrup; Johan W Mouton; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

6.  β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.

Authors:  Kimberly E Hanson; Christopher D Pfeiffer; Erika D Lease; Alfred H Balch; Aimee K Zaas; John R Perfect; Barbara D Alexander
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

7.  Intraleukocytic Candida is Diagnostic of Pathological Candidemia.

Authors:  Anil Handoo; Sarada Nagoti; Adarsh Choudhary
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

Review 8.  Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment.

Authors:  Lorena de Oliveira Felipe; Willer Ferreira da Silva Júnior; Katialaine Corrêa de Araújo; Daniela Leite Fabrino
Journal:  Braz J Microbiol       Date:  2017-11-11       Impact factor: 2.476

9.  Candidemia in non-ICU surgical wards: Comparison with medical wards.

Authors:  Antonio Vena; Emilio Bouza; Maricela Valerio; Belén Padilla; José Ramón Paño-Pardo; Mario Fernández-Ruiz; Ana Díaz Martín; Miguel Salavert; Alessandra Mularoni; Mireia Puig-Asensio; Patricia Muñoz
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

10.  Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.

Authors:  Chun-fang Ma; Fang-qiu Li; Li-ning Shi; Yu-an Hu; Ying Wang; Mei Huang; Qian-qian Kong
Journal:  BMC Infect Dis       Date:  2013-07-22       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.